Although previous studies have shown that upregulation of IGFLR1 could indicated poor OS and DFS survival in ccRCC patients (Parker et al., 2002; Schips et al., 2004; Lkhagvadorj et al., 2014), the study was limited to a small sample. This evidence concerns the gene IGFLR1 and nonpapillary renal cell carcinoma.